☰

Richard R. Chapleau, Ph.D. - Publications

Affiliations: 
2003-2009 Chemistry University of California, Santa Barbara, Santa Barbara, CA, United States 
 2012-2014 Henry M Jackson Foundation for the Advancement of Military Medicine 
 2014-2020 Aeromedical Research US Air Force School of Aerospace Medicine 
 2016- Biochemistry & Molecular Biology Wright State University, Fairborn, OH, United States 
 2020-2022 Public Health & Preventive Medicine US Air Force School of Aerospace Medicine 
 2022- Genetics NeuroStat Analytical Solutions 
Area:
Biochemistry, Genetics
Tree Info Similar researchers PubMed Report error

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Skarzynski M, McAuley EM, Maier EJ, Fries AC, Voss JD, Chapleau RR. SARS-CoV-2 Genome-Based Severity Predictions Correspond to Lower qPCR Values and Higher Viral Load. Global Health, Epidemiology and Genomics. 2022: 6499217. PMID 35707747 DOI: 10.1155/2022/6499217  0.29
2022 Radwan O, Brothers MC, Coyle V, Chapleau ME, Chapleau RR, Kim SS, Ruiz ON. Electrochemical biosensor for rapid detection of fungal contamination in fuel systems. Biosensors & Bioelectronics. 211: 114374. PMID 35605548 DOI: 10.1016/j.bios.2022.114374  0.31
2022 Palmieri D, Javorina A, Siddiqui J, Gardner A, Fries A, Chapleau RR, Starr C, Fishel R, Miles WO. Mass COVID-19 patient screening using UvsX and UvsY mediated DNA recombination and high throughput parallel sequencing. Scientific Reports. 12: 4082. PMID 35260723 DOI: 10.1038/s41598-022-08034-1  0.672
2022 Chapleau RR, Regn DD, de Castro MJ. Surveying the Genomic Landscape Supporting the Development of Precision Military Aerospace Medicine. Aerospace Medicine and Human Performance. 93: 89-93. PMID 35105425 DOI: 10.3357/AMHP.5929.2022  0.265
2021 Voss JD, Skarzynski M, McAuley EM, Maier EJ, Gibbons T, Fries AC, Chapleau RR. Variants in SARS-CoV-2 associated with mild or severe outcome. Evolution, Medicine, and Public Health. 9: 267-275. PMID 34447577 DOI: 10.1093/emph/eoab019  0.238
2021 Chapleau RR, Christian M, Connors B, Premo C, Chao TC, Rodriguez J, Huntsberger S, Meyer J, Javorina A, Reynolds K, Riddle D, Lisanby M, Starr C. Early Identification of SARS-CoV-2 Emergence in the Department of Defense via Retrospective Analysis of 2019-2020 Upper Respiratory Illness Samples. Msmr. 28: 2-5. PMID 34379377  0.673
2021 Chapleau RR, Regn DD. Integrating the precision, sleep, and aerospace medicine fields: a systematic review of the genetic predisposition for obstructive sleep apnea in military aviation. Sleep & Breathing = Schlaf & Atmung. PMID 34231084 DOI: 10.1007/s11325-021-02427-8  0.219
2019 Chapleau RR, Martin CA, Hughes SR, Baldwin JC, Sladky J, Sherman PM, Grinkemeyer M. Apolipoprotein E promoter genotypes are not associated with white matter hyperintensity development in high-altitude careers. Bmc Research Notes. 12: 630. PMID 31551090 DOI: 10.1186/s13104-019-4654-9  0.227
2019 Hughes SR, Chapleau RR. Comparing DNA quantity and quality using saliva collection following food and beverage consumption. Bmc Research Notes. 12: 165. PMID 30904022 DOI: 10.1186/s13104-019-4211-6  0.283
2019 Meyer J, Bear K, Buwolda M, Sorio L, Regn D, Ford C, Chapleau R. 0020 Evaluating Genetic Variation as a Possible Method for Increasing Surveillance and Managing Risk of Developing Obstructive Sleep Apnea Sleep. 42: A8-A8. DOI: 10.1093/SLEEP/ZSZ067.019  0.208
2018 Chapleau RR, Martin CA, Hughes SR, Baldwin JC, Sladky J, Sherman PM, Grinkemeyer M. Evaluating apolipoprotein E genotype status and neuroprotective effects against white matter hyperintensity development in high-altitude careers. Bmc Research Notes. 11: 764. PMID 30359295 DOI: 10.1186/s13104-018-3867-7  0.217
2017 Huntsberger SA, Butler WP, Chapleau RR. Patient-Centric Side Effect Risk Assessment for Medications Used During Aeromedical Evacuations. Aerospace Medicine and Human Performance. 88: 423-426. PMID 28518007 DOI: 10.3357/AMHP.4748.2017  0.233
2015 Chapleau RR, Baldwin JC. Optical Whole-Genome Restriction Mapping as a Tool for Rapidly Distinguishing and Identifying Bacterial Contaminants in Clinical Samples. Journal of Clinical and Diagnostic Research : Jcdr. 9: DC24-7. PMID 26435946 DOI: 10.7860/JCDR/2015/13983.6408  0.253
2015 Ruark CD, Chapleau RR, Mahle DA, Gearhart JM. Organophosphorus Inhibition and Characterization of Recombinant Guinea Pig Acetylcholinesterase. Protein and Peptide Letters. 22: 862-8. PMID 26216268  0.222
2015 Chapleau RR, McElroy CA, Ruark CD, Fleming EJ, Ghering AB, Schlager JJ, Poeppelman LD, Gearhart JM. High-Throughput Screening for Positive Allosteric Modulators Identified Potential Therapeutics against Acetylcholinesterase Inhibition. Journal of Biomolecular Screening. PMID 26078409 DOI: 10.1177/1087057115591006  0.261
2015 Starr CR, Villazana ET, Chapleau RR, Masserang DL. Optimizing the Roche LightCycler(R) for Single-Tube Multiplexed RT-PCR Assays. Journal of Clinical and Diagnostic Research : Jcdr. 9: DM01-3. PMID 25737991 DOI: 10.7860/JCDR/2015/9819.5361  0.658
2015 Chapleau RR, Frey JS, Riddle DS, Ruiz ON, Mauzy CA. Measuring Single-Domain Antibody Interactions with Epitopes in Jet Fuel Using Microscale Thermophoresis Analytical Letters. 48: 526-530. DOI: 10.1080/00032719.2014.947535  0.203
2015 Chushak YG, Chapleau RR, Frey JS, Mauzy CA, Gearhart JM. Identifying potential protein targets for toluene using a molecular similarity search, in silico docking and in vitro validation Toxicology Research. 4: 519-526. DOI: 10.1039/c5tx00009b  0.298
2014 Chapleau RR, Robinson PJ, Schlager JJ, Gearhart JM. Potential new therapeutic modality revealed through agent-based modeling of the neuromuscular junction and acetylcholinesterase inhibition. Theoretical Biology & Medical Modelling. 11: 42. PMID 25273339 DOI: 10.1186/1742-4682-11-42  0.225
2014 Martin JA, Chávez JL, Chushak Y, Chapleau RR, Hagen J, Kelley-Loughnane N. Tunable stringency aptamer selection and gold nanoparticle assay for detection of cortisol. Analytical and Bioanalytical Chemistry. 406: 4637-47. PMID 24880870 DOI: 10.1007/s00216-014-7883-8  0.299
2009 Chapleau RR, Sagermann M. Real-time in vivo imaging of mercury uptake in Caenorhabditis elegans through the foodchain. Toxicology. 261: 136-42. PMID 19460414 DOI: 10.1016/J.Tox.2009.05.005  0.682
2009 Sagermann M, Chapleau RR, DeLorimier E, Lei M. Using affinity chromatography to engineer and characterize pH-dependent protein switches. Protein Science : a Publication of the Protein Society. 18: 217-28. PMID 19177365 DOI: 10.1002/Pro.23  0.665
2008 Chapleau RR, Blomberg R, Ford PC, Sagermann M. Design of a highly specific and noninvasive biosensor suitable for real-time in vivo imaging of mercury (II) uptake. Protein Science : a Publication of the Protein Society. 17: 614-22. PMID 18305194 DOI: 10.1110/Ps.073358908  0.685
Show low-probability matches.